CHIRLOYO
LIVE

Serial Number

79448562

Owner

ZEALAND PHARMA A/S

Filing Date

Mar 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CHIRLOYO Trademark

Serial Number: 79448562

CHIRLOYO is a trademark filed by ZEALAND PHARMA A/S on March 18, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ZEALAND PHARMA A/S (41 trademarks)

SØBORG 2860 , DK

Entity Type: 03

Trademark Details

Filing Date

March 18, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); pharmaceutical preparations, namely for treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia; medical preparations for the treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia.

Medical and pharmaceutical services, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical advice, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical services, namely in relation to treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia; medical and pharmaceutical advice, namely in relation to treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia.

Devices for introducing pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS), and parts and fittings therefor; devices for introducing pharmaceutical preparations, namely for treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia, and parts and fittings therefor.

Filing History

ASSIGNED TO EXAMINER
Jun 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 23, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 23, 2026 REPR